How is Safety Monitored in Pediatric Antibiotic Use?
Safety is paramount in pediatric antibiotic use. Adverse effects can be more severe in children, and long-term impacts are often unknown. Regulatory agencies like the FDA and EMA have stringent guidelines for pediatric drug trials to ensure safety. Post-marketing surveillance is also critical to monitor any adverse effects that may not have been evident in clinical trials.
